Pabst Patent Group LLP
Methods of administering an N-terminal modified PEG-TRAIL
Disclosed herein are an N-terminal modified PEG-TRAIL conjugates and methods of making and using thereof. The PEG-TAIL conjugates have bioactivity that is substantially similar to that of native TRAIL coupled with an extended in vivo half-life and enhanced stability. The disclosed PEG-TRAIL conjugates exhibit significantly reduced hepatotoxicity when compared to that of non-PEGylated trimeric TRAIL. The disclosed methods of making the PEG-TRAIL conjugates provide a homogeneous, highly pure, form of N-terminal modified PEG-TRAIL. Compared to native TRAIL, the PEG-TRAIL conjugates exhibits high solubility and solution stability. The PEG-TRAIL conjugates are useful in preventing and treating proliferative or autoimmune diseases.
D&D Pharmatech Inc.
A A C A C A G A B C A C A
A61P A61P C07K A61K C07K A61P G01N A61K B01D C07K A61K C07K A61P
inventional inventional inventional additional inventional inventional additional inventional additional additional inventional additional inventional
Seulki Kang Choon Eun Ji
Lee Lee Park